Tat-specific antibodies associated with better HIV-associated motor function

Area of Science:

• Neuroscience
• Immunology
• Virology

Background:

• HIV Tat protein can be secreted and cause central nervous system damage, including dopaminergic neuron dysfunction.
• This dysfunction may contribute to Parkinsonian motor features observed in people with HIV (PWH).

Purpose of the Study:

• To investigate the association between anti-Tat antibodies and extrapyramidal motor dysfunction in PWH.
• To explore the potential protective role of anti-Tat antibodies against HIV-associated neurological complications.

Main Methods:

• Quantified anti-Tat IgG levels in plasma and cerebrospinal fluid of 42 chronically HIV-infected individuals.
• Assessed extrapyramidal motor abnormalities using the Unified Parkinson's Disease Rating Scale (UPDRS).
• Evaluated the in vitro activity of plasma and animal sera against Tat-induced transactivation.

Main Results:

• Lower anti-Tat IgG levels, particularly against the cysteine-rich Tat region, correlated with more severe motor abnormalities (higher UPDRS scores).
• HIV antibody responses to Tat were generally weak compared to other HIV antigens, even in early infection.
• Plasma from PWH showed no inhibitory activity against Tat transactivation, while Tat-immunized animal sera demonstrated potent inhibition.

Conclusions:

• Suggests a potential protective role for anti-Tat antibodies in mitigating HIV-associated dopaminergic dysfunction.
• Raises the possibility of developing a therapeutic Tat vaccine to alleviate Parkinsonian motor symptoms in PWH.